Search Results

This week's highlights include congrats to: Bruce Allen , Terence Hébert , et al. for their work on Understanding Terry Kenakin and Sam Hoare ! Terry Kenakin on what to anticipate for these courses!

Terry illustrates this with classic β-receptor partial agonists, showing how heart rate set-points under Terry’s Corner exists to fix that blind spot. Why Terry’s Corner Most pharmacology training freezes at equilibrium snapshots.

Terry Kenakin with our premium membership and enjoy a 1-month FREE trial! Terry Kenakin Reading Materials Access to the private group Certificate of participation Learn the essentials

Premium Members also receive a 50%+ discount on Terry’s Corner — unlocking advanced pharmacology depth Terry Kenakin (for a limited time).

toxicophores accelerates rational design cycles Computational prediction complements biological screening Why Terry ’s Corner Terry’s Pharmacology Corner delivers weekly in-depth lectures by Dr.

Terry Kenakin, these five modules reveal how location bias, intracellular signaling, and ligand kinetics

Terry’s Corner: GPCR Pharmacology Insights That Prevent Real Drug Discovery Failures Discovery collapses Premium Members get 67% discount when they join Terry’s Corner in 2025 Sharpen your interpretation skills

Terry’s Corner: Schild Analysis — Why It Matters Most assays show a clean rightward shift and we assume Premium Members get 50%+ discount  when they join Terry’s Corner.

Terry's Corner – Designing Drugs That Anticipate Physiological Pushback Most GPCR programs don’t fail This week’s Terry’s Corner  exposes the unseen physiological “opponents” your molecule faces—and how

Terry's Corner – Orthosteric vs. This week in Terry's Corner, we focuse on the distinction between orthosteric and allosteric mechanisms overdose risk without sacrificing meaningful efficacy. 🎬 Plus New: Lesson Trailers   Curious about Terry

Watch the course trailer 👇 Why Terry’s Corner Weekly pharmacology lectures by Dr. Terry Kenakin, monthly AMAs, and a growing on-demand library help scientists sharpen fundamentals, challenge

Terry's Corner – How Enzyme Inhibition Shapes Every Discovery Program Every molecule meets an enzyme This week’s Terry’s Corner reframes inhibition not as background theory—but as a design lens for smarter

Terry Kenakin  and Sam Hoare ! Terry Kenakin to gain insights and prepare for upcoming courses.

Terry Kenakin! Terry Kenakin Reading Materials Access to the private group Certificate Explore: Key metrics for assessing

Why Terry’s Corner Give You The GPCR Pharmacology Insights You Need Terry’s Corner gives discovery scientists

Terry Kenakin  and Sam Hoare ! Registration Closes Tomorrow! Terry Kenakin to acquire valuable insights and prepare for the upcoming courses.

Terry Kenakin's educational initiative this fall!

Stuart Maudsley, Nicole Perry-Hauser, Lauren Slosky, Cesare Orlandi, and Simone Prömel. Terry Kenakin's "Applying Pharmacology to Drug Discovery" course at Dr.

Terry W. Moore, was most definitely a success.

Terry Kenakin and Sam Hoare ! Terry Kenakin as he shares insights into what you can anticipate for the upcoming courses.

liabilities, or identify true best-in-class candidates faster Unlock “Drug Binding Kinetics” Now Only in Terry

Terry Kenakin will conduct two consecutive courses in September and October 2024.

Nicole Perry-Hauser, on her selection as a 2024 Discovery Science Emerging Scholar at Vanderbilt University Terry Kenakin. The course covers basic pharmacology in four weekly segments.

It took data, yes—but also a deep partnership with GPCR legend Terry Kenakin to bridge industry credibility

Terry Kenakin's educational initiative this fall!

Terry Kenakin will return for two consecutive courses in September and October 2024.

Terry Kenakin.

Terry Kenakin will lead two brand-new, back-to-back courses tailored for the Dr.

Terry Kenakin.

Terry Kenakin will return for two consecutive courses in September and October 2024.